Breast cancers with EGFR and HER2 co-amplification favor distant metastasis and poor clinical outcome.

about

Breast cancers with EGFR and HER2 co-amplification favor distant metastasis and poor clinical outcome.

Item

http://www.wikidata.org/entity/Q47135806

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Breast cancers with EGFR and H ...... sis and poor clinical outcome.

@en

Breast cancers with EGFR and H ...... sis and poor clinical outcome.

@nl

type

Item

label

Breast cancers with EGFR and H ...... sis and poor clinical outcome.

@en

Breast cancers with EGFR and H ...... sis and poor clinical outcome.

@nl

prefLabel

Breast cancers with EGFR and H ...... sis and poor clinical outcome.

@en

Breast cancers with EGFR and H ...... sis and poor clinical outcome.

@nl

P1476

Breast cancers with EGFR and H ...... sis and poor clinical outcome.

@en

P2093

Feng Ye

http://www.w3.org/2001/XMLSchema#string

Hong Bu

http://www.w3.org/2001/XMLSchema#string

Hong Zheng

http://www.w3.org/2001/XMLSchema#string

Lina Chen

http://www.w3.org/2001/XMLSchema#string

Peng Guo

http://www.w3.org/2001/XMLSchema#string

Shinan Chen

http://www.w3.org/2001/XMLSchema#string

Tianjie Pu

http://www.w3.org/2001/XMLSchema#string

Xiaorong Zhong

http://www.w3.org/2001/XMLSchema#string

Yan Qiu

http://www.w3.org/2001/XMLSchema#string

P2860

Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members

Comprehensive molecular portraits of human breast tumours

Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Profile of neratinib and its potential in the treatment of breast cancer

ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis.

A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice

The quest to overcome resistance to EGFR-targeted therapies in cancer.

P304

6562-6570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.7051

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29181099

http://www.w3.org/2001/XMLSchema#string

P932

5696709

http://www.w3.org/2001/XMLSchema#string